Curcumin Disrupts a Positive Feedback Loop between ADMSCs and Cancer Cells in the Breast Tumor Microenvironment via the CXCL12/CXCR4 Axis
Adipose tissue has a significant impact on breast cancer initiation and progression owing to its substantial proportion in the breast. Adipose-derived mesenchymal stem cells (ADMSCs) are major players in the breast tumor microenvironment (TME) as they interact with cancer cells. The intricate interaction between ADMSCs and cancer cells not only drives the differentiation of ADMSCs into cancer-associated fibroblasts (CAFs) but also the metastasis of cancer cells, which is attributed to the CXCL12/CXCR4 axis. We investigated the effects of curcumin, a flavonoid known for CXCL12/CXCR4 axis inhibition, on breast TME by analyzing whether it can disrupt the ADMSC-cancer positive loop. Using MCF7 breast cancer cell-derived conditioned medium (MCF7-CM), we induced ADMSC transformation and verified that curcumin diminished the phenotypic change, inhibiting CAF marker expression. Additionally, curcumin suppressed the CXCL12/CXCR4 axis and its downstream signaling both in ADMSCs and MCF7 cells. The CM from ADMSCs, whose ADMSC-to-CAF transformation was repressed by the curcumin treatment, inhibited the positive feedback loop between ADMSCs and MCF7 as well as epithelial–mesenchymal transition in MCF7. Our study showed that curcumin is a potent anti-cancer agent that can remodel the breast TME, thereby restricting the ADMSC-cancer positive feedback loop associated with the CXCL12/CXCR4 axis.
Top-30
Journals
|
1
|
|
|
Antibiotics
1 publication, 8.33%
|
|
|
Pharmaceutics
1 publication, 8.33%
|
|
|
Signal Transduction and Targeted Therapy
1 publication, 8.33%
|
|
|
Cancers
1 publication, 8.33%
|
|
|
Asian Journal of Pharmaceutical Sciences
1 publication, 8.33%
|
|
|
ACS Pharmacology & Translational Science
1 publication, 8.33%
|
|
|
International Reviews of Immunology
1 publication, 8.33%
|
|
|
Bioorganic Chemistry
1 publication, 8.33%
|
|
|
Medicina
1 publication, 8.33%
|
|
|
Journal of Translational Medicine
1 publication, 8.33%
|
|
|
Russian Chemical Reviews
1 publication, 8.33%
|
|
|
Cell Death Discovery
1 publication, 8.33%
|
|
|
1
|
Publishers
|
1
2
3
4
|
|
|
MDPI
4 publications, 33.33%
|
|
|
Springer Nature
3 publications, 25%
|
|
|
Elsevier
2 publications, 16.67%
|
|
|
American Chemical Society (ACS)
1 publication, 8.33%
|
|
|
Taylor & Francis
1 publication, 8.33%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 8.33%
|
|
|
1
2
3
4
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.